These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
415 related items for PubMed ID: 26228193
1. Immunosuppressive therapy in patients with IgA nephropathy. Peters HP, van den Brand JA, Berger SP, Wetzels JF. Neth J Med; 2015 Jul; 73(6):284-9. PubMed ID: 26228193 [Abstract] [Full Text] [Related]
2. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran. Soleymanian T, Najafi I, Salimi BH, Broomand B. Ren Fail; 2011 Jul; 33(6):572-7. PubMed ID: 21663387 [Abstract] [Full Text] [Related]
3. [Long-term administration of cyclosporine A in patients with IgA nephropathy]. Chábová V, Tesar V, Zabka J, Rychlík I, Merta M, Jirsa M, Stejskalová A, Stejskal J. Cas Lek Cesk; 1996 Dec 18; 135(24):803-6. PubMed ID: 9072300 [Abstract] [Full Text] [Related]
4. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation. Shen XH, Liang SS, Chen HM, Le WB, Jiang S, Zeng CH, Zhou ML, Zhang HT, Liu ZH. J Nephrol; 2015 Aug 18; 28(4):441-9. PubMed ID: 25585823 [Abstract] [Full Text] [Related]
5. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z. Nephrol Dial Transplant; 2012 Apr 18; 27(4):1479-85. PubMed ID: 21965586 [Abstract] [Full Text] [Related]
6. Can immunosuppressive drugs slow the progression of IgA nephropathy? Goumenos D, Ahuja M, Shortland JR, Brown CB. Nephrol Dial Transplant; 1995 Apr 18; 10(7):1173-81. PubMed ID: 7478120 [Abstract] [Full Text] [Related]
7. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria. Hwang HS, Kim BS, Shin YS, Yoon HE, Song JC, Choi BS, Park CW, Yang CW, Kim YS, Bang BK. Nephrology (Carlton); 2010 Mar 18; 15(2):236-41. PubMed ID: 20470285 [Abstract] [Full Text] [Related]
8. The effects of cytotoxic therapy in progressive IgA nephropathy. Shin JH, Lee JE, Park JH, Lim S, Jang HR, Kwon GY, Huh W, Jung SH, Kim YG, Oh HY, Kim DJ. Ann Med; 2016 Mar 18; 48(3):171-81. PubMed ID: 27031662 [Abstract] [Full Text] [Related]
9. Progression of IgA nephropathy under current therapy regimen in a Chinese population. Li X, Liu Y, Lv J, Shi S, Liu L, Chen Y, Zhang H. Clin J Am Soc Nephrol; 2014 Mar 18; 9(3):484-9. PubMed ID: 24408121 [Abstract] [Full Text] [Related]
10. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy. Cheng G, Liu D, Margetts P, Liu L, Zhao Z, Liu Z, Tang L, Fang Y, Li H, Guo Y, Chen F, Liu F. Nephrology (Carlton); 2015 Feb 18; 20(2):77-84. PubMed ID: 25358874 [Abstract] [Full Text] [Related]
11. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, Wetzels JF. Nephrol Dial Transplant; 2011 Nov 18; 26(11):3581-8. PubMed ID: 21467131 [Abstract] [Full Text] [Related]
12. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy. Manno C, Torres DD, Rossini M, Pesce F, Schena FP. Nephrol Dial Transplant; 2009 Dec 18; 24(12):3694-701. PubMed ID: 19628647 [Abstract] [Full Text] [Related]
13. Predictors of Progression in IgA Nephropathy in Childhood. Mizerska-Wasiak M, Małdyk J, Turczyn A, Cichoń-Kawa K, Rybi-Szumińska A, Wasilewska A, Bieniaś B, Zajączkowska M, Miklaszewska M, Pietrzyk J, Demkow U, Roszkowska-Blaim M, Pańczyk-Tomaszewska M. Adv Exp Med Biol; 2017 Dec 18; 955():65-73. PubMed ID: 27718216 [Abstract] [Full Text] [Related]
14. Increased Serum IgA in Children with IgA Nephropathy, Severity of Kidney Biopsy Findings and Long-Term Outcomes. Mizerska-Wasiak M, Małdyk J, Pańczyk-Tomaszewska M, Turczyn A, Cichoń-Kawa K, Rybi-Szumińska A, Wasilewska A, Firszt-Adamczyk A, Stankiewicz R, Bieniaś B, Zajączkowska M, Gadomska-Prokop K, Grenda R, Miklaszewska M, Pietrzyk J, Pukajło-Marczyk, Zwolińska D, Szczepańska M, Demkow U, Roszkowska-Blaim M. Adv Exp Med Biol; 2015 Dec 18; 873():79-86. PubMed ID: 26269025 [Abstract] [Full Text] [Related]
15. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy. Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Eto T, Nakao H. Ren Fail; 2005 Dec 18; 27(1):45-52. PubMed ID: 15717634 [Abstract] [Full Text] [Related]
16. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine. Pozzi C, Andrulli S, Pani A, Scaini P, Roccatello D, Fogazzi G, Pecchini P, Rustichelli R, Finocchiaro P, Del Vecchio L, Locatelli F. J Nephrol; 2013 Dec 18; 26(1):86-93. PubMed ID: 22460183 [Abstract] [Full Text] [Related]
17. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy. Min L, Wang Q, Cao L, Zhou W, Yuan J, Zhang M, Che X, Mou S, Fang W, Gu L, Zhu M, Wang L, Yu Z, Qian J, Ni Z. Oncotarget; 2017 Jul 18; 8(29):48375-48384. PubMed ID: 28415636 [Abstract] [Full Text] [Related]
18. First-year GFR slope and long-term renal outcome in IgA nephropathy. Lee K, Shin J, Park J, Hwang S, Jang HR, Huh W, Kwon GY, Kim YG, Oh HY, Lee JE, Kim DJ. Eur J Clin Invest; 2018 Jun 18; 48(6):e12936. PubMed ID: 29660832 [Abstract] [Full Text] [Related]
19. [IgA nephropathy - prognostic factors and treatment]. Wieliczko M, Dylewska M. Wiad Lek; 2016 Jun 18; 69(5):707-710. PubMed ID: 28033590 [Abstract] [Full Text] [Related]
20. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review]. Pozzi C, Del Vecchio L, Locatelli F. G Ital Nefrol; 2002 Jun 18; 19(5):523-8. PubMed ID: 12439840 [Abstract] [Full Text] [Related] Page: [Next] [New Search]